Want to join the conversation?
$MRK and $PFE said the study will investigate avelumab in combination with INLYTA (axitinib), tyrosine kinase inhibitor (TKI), in patients with previously untreated advanced RCC, and only Phase 3 trial currently evaluating anti-PD-L1 immunotherapy in combination with vascular endothelial growth factor (VEGF)-receptor TKI in this setting.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.